dihydroxyphenylalanine has been researched along with Agnosia in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Agnosia: Loss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiasse, R | 1 |
| Collignon, R | 1 |
| Bietlot, A | 1 |
| Mahieu, P | 1 |
| Otte, JB | 1 |
| Legrain, Y | 1 |
| Pillen, E | 1 |
1 other study available for dihydroxyphenylalanine and Agnosia
| Article | Year |
|---|---|
[Treatment of fulminant hepatitis with coma by exchange transfusion. Study of 9 patients, including 1 with neurological sequelae in the cortical functions (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Aged; Agnosia; Anti-Bacterial Agents; Brain; Cerebral Cortex; Dihydr | 1974 |